X

Xencor

D
XNCR
USD
0.55
(2.4261%)
Market Closed
14,520.00
Volume
-2.935
EPS
-
Div Yield
-8.062500
P/E
1,623,710,559.24
Market Cap
Today
2.4261%
1 Week
10.545%
1 Month
19.260%
6 Months
-4.247%
12 Months
25.378%
Year To Date
9.065%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
B
BLUE
-0.0729
(-16.2614%)
USD
GILD
GILD
6.23
(6.7946%)
USD
REGN
REGN
8.505
(1.0417%)
USD
I
INCY
1.47
(1.8173%)
USD
B
BMRN
0.885
(1.3401%)
USD
I
ILMN
3.37
(2.2187%)
USD
AMGN
AMGN
0.28
(0.087%)
USD
B
BIIB
-0.32
(-0.1837%)
USD
C
CLDT
0.73
(8.6853%)
USD
T
TGTX
0.7
(2.5735%)
USD

Title:
Xencor

Sector:
Healthcare
Industry:
Biotechnology
Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases such with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045, XmAb662 among others. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.
Do you need help or have a question?
Contact Us